Thiazolidinediones (TZDs) reduced the risk of developing the disease by more than a fifth in a study of more than half a million patients.
The drugs are thought to work by reducing bad cholesterol in the blood and boosting blood flow and oxygen supply to the brain. The Daily Mail
No comments:
Post a Comment